SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-368769
Filing Date
2017-12-14
Accepted
2017-12-14 07:00:32
Documents
2
Period of Report
2017-12-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d506307d8k.htm 8-K 15090
2 EX-99.1 d506307dex991.htm EX-99.1 38604
  Complete submission text file 0001193125-17-368769.txt   54861
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 171255132
SIC: 2836 Biological Products, (No Diagnostic Substances)